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Abstract.  Kinesin is known as a  representative 
cytoskeletal motor protein that is engaged in cell divi- 
sion and axonal transport.  In addition to the mutant 
assay,  recent advances using the PCR cloning tech- 
nique have elucidated the existence of many kinds of 
kinesin-related proteins in yeast, Drosophila,  and 
mice. We previously cloned five different members of 
kinesin superfamily proteins (KIFs) in mouse brain 
(Aizawa, H., Y.  Sekine,  R. Takemura,  Z.  Zhang,  M. 
Nangaku,  and N.  Hirokawa.  1992. J.  Cell Biol. 
119:1287-1296) and demonstrated that one of them, 
KIF3A, is an anterograde motor (Kondo, S.,  R.  Sato- 
Yashitake,  Y.  Noda, H. Aizawa, T.  Nakata,  Y.  Mat- 
suura,  and N. Hirokawa. J.  Cell Biol.  1994. 
125:1095-1107).  We have now characterized another 
axonal transport motor,  KIF2.  Different from other 
KIFs, KIF2 is a central type motor,  since its motor 
domain is located in the center of the molecule. 
Recombinant KIF2 exists as a dimer with a bigger 
head and plus-end directionally moves microtubules at 
a velocity of 0.47  ±  0.11 /~m/s, which is two thirds 
that of kinesin's.  Immunocytological examination 
showed that native KIF2 is abundant in developing 
axons and that it accumulates in the proximal region 
of the ligated nerves after a 20-h ligation.  Soluble 
KIF2 exists without a light chain,  and KIF2's 
associated-vesicles, immunoprecipitated by anti-KIF2 
antibody, are different from those carried by existing 
motors such as kinesin and KIF3A. They are also dis- 
tinct from synaptic vesicles, although KIF2 is accumu- 
lated in so-called synaptic vesicle fractions and em- 
bryonal growth cone particles.  Our results strongly 
suggest that KIF2 functions as a new anterograde mo- 
tor, being specialized for a particular group of mem- 
branous organelles involved in fast axonal transport. 
N 
'EURONS possess a highly polarized cytoarchitecture 
and transport system that  enable them to perform 
their specialized functions. Especially within axons, 
each membrane or substrate is transported at the proper ve- 
locity and direction.  Specialized markers have been used to 
identify  many  kinds  of axonal  transports,  which  can  be 
roughly classified into several groups based on their veloci- 
ties and directions  (Grafstein  and Forma,  1980; Dahlstrtm 
et al., 1992). The variety of cross-bridge structures  connect- 
ing vesicles and microtubules also supports the existence of 
a plural  mechanism  for axonal  transport (Hirokawa et al., 
1982,  1991). 
Kinesin and cytoplasmic dynein are representative motors 
of anterograde and retrograde axonal transport, respectively 
(Vale et al., 1985; Brady et al., 1985; Paschal et al., 1987). 
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To better understand possible involvement  of other motor 
molecules, we previously searched  for new ones and ulti- 
mately applied the PCR method to clone five kinesin-like 
molecules (kinesin  superfamily  proteins [KIFs] 1 1-5) using 
their homology with the kinesin  motor domain (Aizawa et 
al., 1992), and subsequently demonstrated that one of them, 
KIF3A is an anterograde  motor (Kondo et al.,  1994). 
KIF2, another superfamily  member, has a unique struc- 
ture in that its motor domain is located at the center of the 
molecule.  To characterize  this putative motor, we expressed 
KIF2 in a  baculovirus system and then  examined  its bio- 
chemical  behavior,  molecule structure,  and motor activity. 
Results indicate it functions as a plus-end-directed motor. In 
addition,  we characterized  KIF2's distribution  and dynamics 
within ligated axons, as well as further purifying native mol- 
ecules with their binding vesicles via the immunoprecipita- 
tion method; thereby demonstrating  KIF2 to be another fast 
1. Abbreviations  usedin thispaper: KHC, kinesin heavy chain; KIF, kinesin 
superfamily  protein; PVDF,  polyvinylidene  defluoride;  St9,  Spodopetra 
frugiperda  9. 
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membranous organeUes distinct from those carded by kine- 
sin heavy chain CKHC) or KIF3A/B proteins and different 
from synaptic vesicles and their precursors. 
Materials and Methods 
Construction and Transfection of Transfer Vector 
Complete KIF2 eDNA, which was originally cloned into pUC19 (Aizawa 
et ai., 1992),  was reintroduced into pBluescript SK(+). A transfer vector 
was constructed using the pAcYM1 transfer vector (Matsuura et ai., 1987) 
which contains the viral polyhedrin promoter for the expression of the 
cloned cDNA insert. The junction sites were sequenced and determined to 
contain ATG and the termination codons of KIF2. 
The  insect cell  line Spodopetra frugiperda  (SIS)  was propagated in 
TC100 medium (GIBCO BRL, Gaithersburg, MD) supplemented with bac- 
totryptose broth and 10% fetal bovine serum (Summers and Smith, 1987). 
AcRP23.1acZ virus DNA (Kitts et al., 1990) was used because the replace- 
ment of the ~-galactosidase gene by cDNA in the pAcYM1 vector can be 
detected in the presence of X-gal. SD cells were transfected with mixtures 
of linearized AcRF23.1acZ  DNA and pAcYM1/KIF2 by lipofection (lipofec- 
tin; GIBCO BRL) to generate recombinant baculovirus AcKIF2 containing 
KIF2 eDNA resulting from homologous recombination. The recombinant 
virus was purified by two rounds of screening in the presence of X-gal, and 
then grown to high titer stocks (107 plaque4orming U/mi) by serial am- 
plification for the subsequent recombinant KIF2 expression. 
Expression and Purification of  KIF2 
To purify the KIF2 protein, the St9 cell culture (30 ml) was resuspended 
72 h after infection with 1/10 vol of PEM buffer (100 mM Pipes pH 6.8, 
1 mM EGTA, 1 mM MgCI2) containing 0.3 M sucrose, 1 mM DTT,  1 mM 
PMSF and  10  /~g/ml leupeptin.  The  cells were homogenized and cen- 
trifuged at 100,000 g for 30 rain at 4°C to obtain the crude extract. It was 
then supplemented with  100/zg/ml  of taxol-stabilized purified microtu- 
bules, which were prepared as described before (Kondo et al.,  1994),  in- 
cubated at 20°C for 20 rain and then centrifuged at room temperature (r.t.) 
for  15  rain.  This  KIF2-microtubule pellet was resuspended with PEM 
buffer containing 10 mM Mg/ATP and centrifuged to wash out proteins de- 
rived from the SIS cells. KIF2 was then released from microtubules with 
the buffer containing 10 mM ATP and 100 mM NaCI. The resultant super- 
natant was considered as the purified KIF2 fraction, and contained about 
150 ~g/ml KIF2 at over 95% purity. 
For the motility assay, KIF2 was further purified by loading the purified 
KIF2 fraction on a 5-20% linear sucrose density gradient. Fractions of 0.5 
ml were collected and analyzed by SDS-PAGE. 
Physical Properties of  KIF2 
KIF2's molecular weight was determined by the method described by Nan- 
gaku et ai. (1994).  Briefly Stoke's radius (Rs) of SD-expressed KIF2 was 
estimated by gel filtration on a Superose 6 column (Pharmacia, Piscataway, 
N J) and calibrated with standard proteins: catalase, aidolase, bovine serum 
albumin,  and ovalbumin.  Sedimentation coefficients (S20,w) were deter- 
mined by centrifngation in a 5-20% sucrose density gradient using catalase, 
aldolase, bovine serum albumin, or ovaibumin as the internal standard. 
Molecular Structure of  KIF2 
The  recombinant KIF2-microtubule pellet  was  quick-frozen and  deep- 
etched as described by Hirokawa et ai. (1989).  For rotary shadowing elec- 
tron microscopy (EM), a 50-~! sample containing 1/10 vol of purified KIF2 
fraction (final KIF2 concentration 15 ~g/ml, ATP 1 raM, NaCI 10 raM) in 
30% glycerol PEM buffer was sprayed on freshly cleaved mica flakes and 
processed as described by Hirokawa et al.  (1989). 
Motility Assay 
Translocation of microtubules was observed according to procedures ini- 
tially  described by Vale  et  al.  (1985).  We used either fivefold diluted, 
purified KIF2 fraction containing 30/~g/rni of KIF2, 2 raM ATP, and 20 
mM NaCI in PEM buffer, or fractions obtained after the sucrose density 
gradient centrifugation. Each sample (8/~1) was loaded onto a glass cover 
slip, and after 20 min of incubation the unadhered protein was removed and 
replaced with 5 ~l of PEM buffer, 20 ~,M taxol, 5 mM MgATP,  and 50 
#g/ml of  the taxol-stabilized microtubules or polarity-marked microtubules. 
Without removing the unadhered KIF2 protein, microtubules formed tight 
bundles in the solution, and it was impossible  to observe the motility.  Motil- 
ity  was  monitored by  video-eubanced differential interference contrast 
(DIC) microscopy as described by Kondo et al.  (1994).  Polarity-marked 
microtubules were prepared as described by Scholey et al. (1993). 
Polyclonal and Monoclonal Antibody Production 
Recombinant KIF2 was expressed in Escherichia  coli  (E.  coil) using a 
PET3d vector with the full-length KIF2. Crude homogenate was loaded on 
SDS-PAGE and overexpressed  KIF2 was cut out and electrically eluted from 
gels. After emulsification with Freund's adjuvant, the resultant compound 
was injected into rabbits and mice at doses of 0.5 and 0.1 rag, respectively. 
Rabbit serum was affinity purified with a KIF2-bound tripropyl Sepharose 
6B column (Pharmacia). 
Mouse spleen cells were fused with P3-653 myeloma cells using 50% 
polyethylene glycol 4000 (Kohler and Milstein, 1976).  After limiting dilu- 
tion and screening, hybridoma cultures were cloned that secreted antibodies 
against KIF2.  Hybridoma cells were injected into peritoneal cavities of 
nude mice and accumulated ascites were collected and purified with a pro- 
tein A-conjugated Sepharose column (Pharmacia). 
Ligation of  Mouse Peripheral Nerves 
and Immunostaining of Tissues 
Saphenous nerves of 3-wk-old mice were tightly ligated under anesthesia 
(Hirokawa et ai., 1990, 1991). After 20 h, the mice were transcar~ally per- 
fused with 2% paraformaldehyde and 0.1% glutaruldehyde in 0.1 M phos- 
phate buffer (pH 7.4).  Small pieces of nerves both proximal and distal to 
the ligated portions were processed for light microscopy immunocytochem- 
istry. Cerebellum was also similarly fixed by perfusion. 
The ligated nerves were sectioned (10 ~,m) after cryoprotection by a 
cryostat. The sections were incubated with 10% normal goat serum in PBS. 
Next they were stained with affinity purified anti-KIF2 rabbit IgG ('~,10 
~g/ml) for 60 rain at r.t.  Preimmune rabbit serum containing the same 
amount of IgG was used as a control. After washing, the sections were in- 
cubated with biotin-labeled anti-rabhit IgG goat IgG for 60 min, stained 
with horse radish peroxidase-labeled streptoavidin for 5  rain,  and then 
reacted  with  3,3'-diaminobenzidine and  hydrogen peroxide.  They  were 
mounted and observed with a Zeiss Axiophoto microscope. 
Frozen tissue samples were sectioned on a cryostat, and pmincobnted 
with  5%  skim  milk  in  PBS.  They  were  incubated with  25  ~tg/ml  of 
anti-KIF2 monoclonai antibody or normal mouse IgG and then incubated 
with 1:100 rhodamine-labeled anti-mouse IgG second antibody. 
Fractionation of  Brain Tissue 
Multiple fractions from 5-wk~old Wistar rat brain were prepared according 
to standard procedures (Fleicher and Pacer, 1974) with slight modifications 
(Nangaku et ai., 1994).  Briefly, brains from rats were gently homogenized 
with 3 mi of medium/gram of wet tissue. The composition of medium A 
included 0.32 M sucrose, 20 mM Tris-HCl, pH 7.6, and 3 mM MgCI2. The 
homogenate was centrifuged at 700 g for 10 rain at 4°C. This low-speed 
pellet was resuspended with 2.4 M  sucrose buffer with 1 M  MgCI2,  and 
then further centrifuged at 50,000 g for 60 rain to yield a pellet of the nu- 
clear fraction. The low-speed superuatant was centrifuged at 7,000 g for 10 
rain and subsequently centrifuged at 24,000 g for 10 rain to yield a high- 
speed supernatant  ($3)  and  pellet  (P3).  S3  was  further centrifuged at 
105,000  g  for 100 rain to yield a pellet of the microsomal fraction. By 
resuspending P3 in 10 ml of 0.25 M sucrose and centrifuging this suspen- 
sion (24,000 g for 10 min), the mitochondrial fraction was recovered in pel- 
let form. 
Synaptic vesicles were at first prepared by the method of Ueda et al. 
(1979) (see Sato-Yoshitake et al., 1992) and then purified with permeation 
chromatography on controlled-pore glass (CPG 10 Polyol, 3000) (Huttner 
et al.,  1983),  while the growth cone fraction was prepared from 16-d-old 
embryonal mouse brain by the method of Pfenninger (1983)  with slight 
modification (Ellis et al., 1985). Brain was placed in 0.32 M sucrose I mM 
Hepes buffer (pH 7.4) containing 1 mM MgCI2, and then gently homoge- 
nized. After being centrifuged at 700 g  for 15 rain, the supernatant was 
loaded onto top of three layers of a discontinuous sucrose density; 0.75, 1.0, 
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fractions were collected from the top of the interphase of different sucrose 
densities. The A fraction was further pelleted and slowly lysed with hypo- 
osmic buffer containing 6 mM Tris/HCl (pH 8.2) with 0.5 mM EDTA. 
Membrane particles were collected by centrifugation at 80,000 rpm for 60 
min using a Beckman TL100 rotor on a 1 M sucrose cushion. 
AJ~inity Purification of Soluble and 
Membrane-associated KIF2 
Three-day-old  mouse brains were homogenized  in PBS, then centrifuged at 
100,000 g for 30 min at 4°C. the crude extract was loaded on an anti-KIF2 
antihody-conjugated  CNBr Sepharose 4B column (Pharmacia) and washed 
with PBS containing 1 M NaCI. The column was eluted by 0.1 M gl3~ine 
(pH 2.2) and fractions were neutralized with 1 M Tris/HC! (pH 8.0). 
Crude membrane fraction was prepared after centrifuging (100,000 rpm) 
the low-speed  brain supernatant ($2) homogenized  with a 0.32 M sucrose 
and 4 mM Hepes (pH 7.4) buffer containing 1 mM MgCI2  and pmtease in- 
hibitors. This membrane fraction was incubated for 30 min at r.t. with 
CNBr Sepharose beads conjugated with anti-KIF2 antibody, or normal 
mouse IgG, or with protein A-Sepharose beads conjugated via dimethyl- 
pimelumidate, with anti-synaptophysin antibody, or normal mouse IgG. 
The beads were washed with the same buffer, loaded on SDS-PAGE  gels, 
and electrotransferred to PVDF membranes for immunoblotting. Beads 
were also processed for conventional EM. 
Antibodies and Immunoblotting 
The fractionated samples were separated by SDS-PAGE  on 7.5 or 12.5% 
gels and transferred onto PVDF membranes. The sheets were reacted with 
affinity-purified  polyclonai anti-KIF3A antibody, anti-kinesin monoclonal 
antibody (H2), or anti-KIF2 polyclonal antibody, followed  by incubation 
with 125I-protein  A. The sheets were also reacted with antibodies against 
synaptic  vesicle-related  proteins including  SV2, synaptophysin,  synaptotag- 
rain, synaptobrevin, and syntaxin (Buckley et al., 1985; Matthew et al., 
1981; Baumen et al., 1989; Garcia et al., 1994). 
Results 
Biochemical Characterization and Purification of 
Recombinant KIF2 
We used the baculovirus expression system as described by 
Kondo et al. (1994) to investigate the molecular characteriza- 
tion of KIF2. The Sf9-expressed, full-length KIF2 protein 
appeared as a band of abont 100 kD (Fig. 1), being consistent 
with  the  predicted molecular weight  (80,945  D)  obtained 
from the nucleotide sequence (Aizawa et al., 1992). As indi- 
cated in Fig. 1 A, in the absence of ATE KIF2 co-sedimented 
with  taxol-stabilized microtubules  assembled  from  pure 
tubulin. This binding was not significantly enhanced by the 
presence of AMP-PNP (Fig.  1 A, lane 2),  being a  distinct 
property  from  that  of kinesin and  KIF3A  (Kondo  et  al., 
1994). KIF2 co-sedimented with microtubules was released 
from microtubules in the presence of 10 mM ATP and 100 
mM NaCI (Fig. 1 A, lanes 12 and 16). However, its amount 
in the supernatant was low when released by  10 mM ATP 
alone (Fig.  1 A, lanes 10 and 14),  and almost none when 
released by 100 mM NaC1 alone (lanes 11 and 15). This be- 
havior suggests that KIF2 has two microtubule-binding sites, 
i.e., one ATP dependent and the other ATP independent. 
We  purified recombinant  KIF2  by  taking  advantage  of 
these biochemical properties, and Fig. 1 B shows the results. 
Briefly, KIF2 was co-sedimented with taxol-stabilized  micro- 
tubules (Fig. 1 B, lane 5), and this KIF2-microtubule pellet 
was washed with buffer containing  10 mM  ATP (lane  7). 
KIF2 was then released using buffer containing 10 mM ATP 
Figure 1. Biochemical charac- 
terization and  purification of 
recombinant  KIF2  protein. 
(A) Binding of KIF2 protein to 
microtubules.  Crude  extract 
from  KIF2-expressing  Sf9 
cells  was  incubated  with 
purified  microtubules  in 
buffer alone (lanes 1 and 5), 
in  buffer  containing  2  mM 
AMP-PNP (lanes 2 and 6), 2 
mM ATP (lanes 3 and 7), or 
10 mM ATP (lanes 4 and 8). 
The samples were centrifuged 
and  the  pellets  (lanes  1-4) 
and supernatants (lanes 5-8) 
were  separated  on  a  7.5% 
SDS-polyacrylamide gel and 
stained with Coomassie bril- 
liant blue (CBB).  To observe 
the  release  of  KIF2  from 
microtubules,  the  KIF2- 
microtubule  pellet  (lane  1) 
was further resuspended with buffer alone (lanes 9 and 13), with buffer containing 10 mM ATP (lanes 10 and 14),  10 mM NaC1 (lanes 
11 and 15), or 10 mM ATP and 100 mM NaC1 (lanes 12 and 16). The samples were centrifuged again, and the pellets (lanes 9-12) and 
supernatants (lanes 13-16) were analyzed. The black arrowhead points to KIF2 and the white one to tubulin. (B) Purification profile of 
KIF2. Crude homogenate of KIF2-expressing Sf9 cells (lane 2) was clarified by centrifugation (P, lane 3; S, lane 4). The supernatant 
(Crude Extract) was incubated with purified microtubules and centrifuged again (P, lane 5; S, lane 6). The resultant KIF2-microtubule 
pellet was washed with buffer containing 10 mM ATP (P, lane 7; S, lane 8). KIF2 was then released from microtubules by resuspending 
the pellet in buffer containing 10 mM ATP and 100 mM NaC1 (P, lane 9; S, lane 10). For the motility assay, this supernatant (purified 
KIF2 fraction) was further purified by sucrose density gradient centrifugation (lane 11 ). Samples from Sf9 ceils infected with parent virus 
which did not express KIF2 were loaded on the same gel as controls (lane 1 corresponds to lane 2 and lane 12 to lane 10, respectively). 
Lane 13 indicates the molecular size markers (200,  116, 97,  66,  and 42 kD). 
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as a single band (>95 % pure). For the motility assay, though, 
it was further purified by sucrose density gradient centrifu- 
gation (Fig.  1 B,  lane 11 ). 
We estimated the molecular weight of recombinant KIF2 
using M  (1-vr~0.w) =  6pRsNASz0.w. By gel filtration,  Rs was 
estimated as 6.95 rim, while S:0.w was determined to be 5.8S 
by sucrose density gradient centrifugation.  Two trials gave 
the same value for Rs and S20.w. The partial specific volume 
(v) was estimated as 0.73  from the amino acid composition 
(Zamyatnin, 1972). The molecular weight of KIF2 was sub- 
sequently calculated to be 171,000  D, which suggests it is a 
dimer since its predicted molecular weight obtained from the 
nucleotide sequence is 80,945  D. 
Molecular Structure of  Recombinant KIF2 
The structure of purified KIF2 (Fig.  1 B, lane 10) was ini- 
tially  observed  by  low-angle,  rotary  shadowing  EM.  As 
Figure 2. Molecular structure of recombinant KIF2 protein.  (A-E) Electron micrographs showing quick-freeze, deep-etched microtubule 
pellets polymerized with KIF2 (A-C),  with a control sample from Sf9 cells infected with parents virus (D) and with buffer alone (E). 
Numerous projections (arrows)  and regular globular decorations (arrowheads)  appear on the microtubules polymerized with KIF2 in A-C, 
while only tightly packed micrombules are observed in D. (F and G) Electron micrographs  showing rotary shadowed KIF2. F shows a 
typical field, while a gallery of several representative molecules is shown in G. The molecules are similar in size and shape to the globular 
decorations  observed in A and C. Bar,  100 nm. 
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with a diameter of 16.4  5:0.2 nm (n =  118). The diameter 
of each observed molecule was quite homogeneous, and was 
about 1.6 times bigger than the single head domains of kine- 
sin and KIF3A (•10  nm) (Hirokawa et al.,  1989; Kondo et 
al.,  1994). Together with our biochemical data, this result 
suggests  that KIF2  molecules exist mainly as dimer.  The 
stalk domain could not be observed by this method, probably 
due to its instability without the presence of binding mole- 
cules. 
Next we examined the microtubule pellet decorated with 
KIF2  (Fig.  1  B,  lane  5)  by  the  quick-freeze  deep-etch 
method,  where  short  stalk  domains  were  clearly visible 
(",,17-nm long), being cross-linked to adjacent microtubules 
(Fig.  2,  A  and  B  arrows).  Globular  structures tended to 
decorate the surface of microtubules in  a  regular pattern 
(Fig. 2, A and C, arrowheads). They were similar in size and 
shape to the structures revealed by rotary shadowing EM, 
and adjoined one end of the stalk domain. From these data, 
we hypothesize that the unique NH2-terminal region of the 
KIF2 protein may form a globular subdomain with the mid- 
die motor region, while the t~-helicai  COOH-terminal re- 
gion forms a  short stalk domain. 
Motor Activity of  Recombinant KIF2 
To prove KIF2 is a motor protein, a motility assay was per- 
formed with recombinant KIF2 protein in vitro as described 
by Kondo et al.  (1994).  The purified Sf9-expressed KIF2 
fraction (Fig.  1 B, lane 10) translocated purified microtu- 
bules on a glass surface at 0.47 +  0.11 gm/s (n =  36). The 
similarly prepared fraction obtained from Sf9 cells infected 
with parent virus (Fig. 1 B, lane 12) showed no motor activ- 
ity indicating that this microtubule translocation activity is 
due to KIF2. Moreover, among the sucrose density gradient 
fractions, only the peak fractions (Fig. 1 B, lane//) translo- 
cated microtubules on the glass surface; thus clearly demon- 
strating that this motor activity is not caused by other Sf9- 
derived motor proteins, but solely by KIb2. 
Polarity-marked microtubules  were observed next.  For 
this assay, purified tubulin was incubated with fragments of 
Chlamydomonas  flagellar  axonemes,  producing  a  longer 
microtubule segment at the plus end and a shorter one at the 
minus  end.  As  indicated  in  Fig.  3,  all  polarity-marked 
microtubules glided with their minus ends leading (n =  31), 
proving that KIF2 is a plus-end-directed microtubule-based 
motor protein. 
Figure 3. Movement of polar- 
ity  marked  microtubules  on 
recombinant  KIF2.  Two  se- 
ries of video images taken at 
30-s  intervals  are  shown. 
Small arrows indicate the axo- 
neme seed, white arrowheads 
the minus end of the seed, and 
black arrowheads the plus end 
of microtubules polymerized 
from the seed. The seeds are 
leading as microtubules trans- 
locate across the eoverslip, in- 
dicating that KIF2 is a plus- 
end--directed motor  protein. 
Bar, 5 pro. 
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and monoclonal antibodies. (Lane 1 ) CBB staining of PVDF mem- 
brane of  mouse total brain homogenate transferred on postnatal day 
4 (P4). The same sheets were immunoblotted with anti-KIF2 poly- 
clonal (lane 2) and monoclonal (lane 3) antibodies. Both antibodies 
bind specifically to KIF2 in total brain homogenate. (B) Western 
blot analysis of KIF2's tissue distribution. Each lane contains 1 mg 
of  tissue total homogenate of mouse brain at P4. Lane 1, cerebrum; 
lane 2, cerebellum; lane 3, lung; lane 4, liver; lane 5, kidney; lane 
6, heart; lane 7, spleen; lane 8, thymus. KIF2 is predominantly ex- 
pressed in brain and at a minor level in other tissues. (C) Western 
blot analysis of KIF2's developmental expression in mouse brain. 
Each lane contains 2 mg of total brain homogenate at P3, P7, PI4, 
and P50. KIF2 is abundant in younger brain (P3 '~ P7). 
Western Blot Analysis of  KIF2's Distribution 
We raised polyclonal and monoclonal antibodies to recom- 
binant KIF2,  and both specifically bound to KIF2  in  the 
mouse total brain homogenate (Fig.  4  A).  Using  affinity- 
purified polyclonal antibody, we analyzed the tissue distribu- 
tion and developmental expression of KIF2 by immunoblot- 
ring (Fig. 4, B and C), where KIF2 was abundantly present 
in the whole brain, less so in the spleen and thymus, much 
less so in the lung, while faint bands were detected in all the 
other tissues (Fig. 4 B). The amount of  most KIF2 expressed 
in the brain decreased postnatally, and only a little was de- 
tected in adult brain  (Fig.  4  C).  These data indicate that 
KIF2 is dominantly expressed in the young nervous system 
of mice in spite of its ubiquitous existence in all tissues. 
Immunocytochemical Analysis of  KIF2 
We examined KIF2's developmental localization in various 
regions  of the mouse central nervous system, and  it was 
found to be transiently expressed in postmitotic young neu- 
rons,  especially  in  developing  axons.  In  the  cerebellum 
where the tissues develop postnatally, KIF2 showed peak ex- 
pression at P7. As shown in Fig. 5, at P7, parallel fibers lo- 
cated in molecular layer were stained most intensely, in addi- 
tion to the occurrence of dot-like staining of the granular 
cells' cell bodies and synapses from mossy fibers. The Pur- 
kinje cells' axons present in the white matter should also be 
noted. However, the external granular layer was not stained, 
which consists of neuroprecursor cells formed during or just 
after mitosis. Staining of the molecular layer faded out from 
inner side (Fig. 5, asterisk) at P14, which was coordinated 
with  the termination of axonal growth,  and  became very 
weak in the adult cerebellum (data not shown). Simultane- 
ously, staining of the white matter also vanished. In the ol- 
factory bulb, where neurite outgrowth persists for life, stain- 
ing did not decrease in adult tissue (data not shown). 
Localization of  KIF2 in Ligated Peripheral Nerves 
Since recombinant KIF2 was found to be a plus-end- directed 
microtubule-based motor in vitro (Fig. 3), and correspond- 
ing staining of axons occurred in vivo (Fig. 5), this protein 
must play some role in axonal transport. To elucidate KIF2's 
dynamics within axons, we observed its localization after 
ligating the peripheral (saphenous) nerves of  adult mice. Our 
previous research has demonstrated that anterogradely and 
retrogradely transported  membranous  organelles,  respec- 
tively, accumulate at the proximal and distal region of the 
l~gure 5. Immnnofluorescence  micrographs 
of developing cerebellum.  Numbers  indi- 
cate the postnatal days. Intense staining of 
molecular layer at P7 dramatically dimin- 
ished from the inner side at P14 (asterisk, 
inner side of the molecular layer). M, mo- 
lecular layer. Bar, 100/~m. 
The Journal of Cell Biology.  Volume 129, 1995  162 Figure 6. Immunofluorescence  micrographs of the ligated nerves with anti-KIF2 antibody. (A) Proximal region. (B) Distal region of the 
ligated  portion. The right side of  A and left side of  B are near the ligated portion, with about 450 #m of separation. (C) Higher magnification 
of the proximal region. (D) Control of proximal region stained with normal rabbit IgG as the first antibody. Arrowheads indicate the ac- 
cumulation of KIF2. Bars: (A, B, and D)  100 #m; 50 #m (C). 
ligated portion (Hirokawa et al., 1990,  1991). After 20 h of 
ligation, the KIF2 polyclonal antibody strongly stained the 
proximal region, though much less so the distal one (Fig. 6 
A, arrowheads). Higher magnification  showed staining in the 
axonal cytoplasm, where the storage of membranous or- 
ganelles increased the diameter (Fig. 6 C). Although we had 
observed  the  accumulation of kinesin and KIF3A in  6-h 
ligated nerves, we could not detect KIb2 after 6 h of  ligation. 
We surmise it is due to smaller volume of KIF2 in the adult 
peripheral nerves compared to those of kinesin and KIF3A 
(unpublished data). In addition, we noticed that in case of 
KIF2,  compared to  ldnesin  (Hirokawa et  al.,  1991) and 
KIF3A (Kondo et al., 1994), the accumulated regions tended 
to be more distant from the ligated portions. 
Subcellular Localization of KIF2 
Because KIF2 was co-localized with membranous organelles 
during axonal anterograde transport, we further investigated 
its intracellular compartment by subcellular fractionation. In 
contrast  to  kinesin  and  KIF3A,  which  are  diffusely dis- 
tributed in all fractions, KIF2 was relatively concentrated in 
the microsome and crude synaptic vesicle fractions, whereas 
not so in the cytosol (Fig. 7 A). Since KIF2 was abundantly 
expressed in the juvenile neurons during axonal growth, we 
isolated  growth  cones  according  to  Pfenninger's  method 
(1983) (Ellis et al.,  1985).  Western blotting results showed 
it to be packed in growth cone particles in embryonal brain, 
and that it mainly associates with the membrane fraction af- 
ter hypo-osmic lysis of growth cones (Fig. 7 B). 
AJ~nity Purification of KIF2 
To further investigate the subpopulation of membranous or- 
ganelles associated with KIF2, we immunologically isolated 
them. The soluble fraction from crude brain extract was ini- 
tially purified in an anti-KIF2 monoclonal antibody-con- 
jugated Sepharose column, and the eluted fraction contained 
a  single band of KIF2, but included no associated protein 
such as a light chain (Fig. 8 A). Next, membrane-associated 
KIF2 was isolated by immunopreeipitation with anti-KIF2 
antibody-conjugated Sepharose beads.  The total brain ho- 
mogenate at P3 was then centrifuged twice at low and high 
speeds. The high-speed pellet was resuspended and reacted 
with antibody-conjugated  beads, with EM showing relatively 
uniform vesicles (100-120-nm diam) located on the surface 
of the beads (Fig. 9 A, arrowheads), while none being pres- 
ent on the normal IgG-conjugated ones (Fig. 9 B); hence, 
indicating KIF2 immunoprecipitated in membrane bound 
form. At higher magnification, vesicles are mostly uniform 
in size (100-120  rim), and sometimes partial multivesicular 
bodies were also observed, consistent with its existence in 
growth cones. This suggests a possibility that some popula- 
tion of partial multivesicular bodies are conveyed antero- 
gradely in the axon. In fact we observe a small population 
of small multivesicular bodies in the proximal region of the 
ligated axons (see Fig. 3 A in Hirokawa et al.,  1990). 
Immunoblotting of.this beads fraction definitely showed 
that these membranous organdies are associated with KIF2, 
but that they are different from kinesin- or KIF3A-binding 
ones (Fig. 8 B). We also tried to detect KIF4-bound mem- 
Noda et al. KIF2, a New Anterograde Axonal Transport Motor  163 Figure  7.  Immunoblot  analysis  of subcellular  fractionation.  (A) 
Subcellular fractions obtained from 5-wk-old rat brain. A 20 tzg of 
sample was loaded on each lane. Lane 1, crude homogenate; lane 
2, cytosol fraction; lane 3, microsomal fraction; lane 4, mitochon- 
drial fraction; lane 5, synaptic vesicle fraction; lane 6, nuclear frac- 
tion.  KIF2 is relatively concentrated  in microsomal and synaptic 
vesicle fractions. (B) Purification process of growth cone particles 
from mouse embryonal brain. Low-speed supernatant of  embryonal 
brain was loaded on a discontinuous sucrose densities (P, preloaded 
supernatant) and S, A, B, C fractions were obtained (S, 0.32 M su- 
crose  fraction,  corresponding  to the  cytosol  fraction;  A,  B,  C, 
boundary  fraction between 0.32 and 0.75 M, 0.75 and 1.0 M, and 
1.0 and 2.7 M sucrose buffer, respectively). The A fraction, corre- 
sponding to the growth cone particles,  was further pelleted down 
by centrifugation (fraction G) and lysed by hypo-osmic shock, then 
centrifuged again on a 1 M sucrose cushion to obtain a membra- 
nous fraction as a pellet (fraction M). (T) total brain homogenate. 
Note KIF2 is concentrated in the membrane fraction of the growth 
cones. 
branous organeUes, but we could not, because of its lower 
expression level at this developmental stage. KIF4 was found 
to be expressed abundantly at earlier stages than KIF2 (data 
not shown). 
Although subcellular fraction data indicates KIF2's abun- 
dance  in  the  crude  synaptic  vesicle  fraction,  membrane 
markers of the  synaptic  vesicles,  i.e.,  synaptophysin and 
SV2, were not associated with KIF2 binding vesicles (Fig. 
8 B). In addition, other synaptic vesicle-related proteins in- 
eluding synaptotagmin, synaptobrevin, and synataxin were 
not concentrated in this KIF2-associated beads fraction (data 
not  shown).  Immunoprecipitation  of  vesicles  with  anti- 
synaptophysin antibody  also  failed to  detect  KIF2 in  the 
synaptophysin-associated beads fraction (Fig. 8 C). Further 
purification  of  crude  synaptic  vesicle  fraction  by  CPG 
column enabled KIF2 bound membrane fraction to separate 
from pure synaptic vesicles fraction concentrated in synap- 
tophysin (Fig 8 D). This finding is of particular interest be- 
cause even though vesicles associated with KIF2 are con- 
tained  in the  so-called synaptic vesicle fraction,  they are 
distinct in nature from synaptic vesicles. 
Figure 8.  Affinity purification  of soluble  and  membrane-bound 
KIF2 (A) Affinity purification of soluble KIF2. (Lane 1 and 2) CBB 
staining of preload supernatant (crude extract of P3 mouse brain) 
(lane 1 ) and eluted fraction (lane 2). Eluted fraction contains only 
KIF2. No associated protein is present.  (B) Immunoblot analysis 
of KIF2-associated vesicles isolated by immunopreeipitation with 
anti-KIF2 monoclonal antibody. The crude membrane fraction was 
incubated with anti-KIF2 antibody lanes K2) or normal mouse IgG 
(lanes  C)  conjugated beads.  Supernatants  (lanes  S)  and  pellets 
(lanes P) were recovered by sedimentation and loaded on SDS- 
polyacrylamide gel and transferred to PVF membrane for immuno- 
blot with anti-kinesin,  KIF2, KIF3A, SV2, and synaptophysin anti- 
bodies. KIF2-associated vesicles include neither kinesin, KIb3A, 
SV2, nor  synaptophysin.  (C) Immunoblot analysis  of synapto- 
physin-associated vesicles isolated by immunoprecipitation. Super- 
natants  (lane S) and pellets (lane P) after being incubated with 
anti-synaptophysin  (lanes 38) and normal mouse IgG (lanes  C) 
conjugated beads were immunoblotted with anti-KIF2 and synap- 
tophysin antibodies. (D) lmmunoblot analysis of  crude (lane 1 ) and 
pure synaptic vesicle fraction (lane 2) with anti-KIF2 and synap- 
tophysin antibodies. KIF2 did not concentrate in the synaptic vesi- 
cles purified with CPG column. 
Discussion 
We have elucidated KIF2's biochemical behavior, molecular 
structure,  motor activity, and cellular/subcellular  distribu- 
tion.  Our  results  indicate  the  following:  (a)  KIF2 has  an 
ATP-dependent  microtubule  binding  site  and  exists  as  a 
dimer without a light chain; (b) KIF2 translocates microtu- 
bules in vitro as a plus-end-directed motor at a velocity two 
thirds that of kinesin; (c) KIF2 is abundant in growing axons; 
(d) KIF2-associated vesicles accumulate in the proximal re- 
gion  of ligated  nerves;  and  (e)  immunologically  isolated 
KIF2-binding  vesicles are different  from those  associated 
with kinesin,  KIF3A, and synaptic vesicle markers. These 
data strongly suggest KIF2 is a new microtubule-based mo- 
tor which carries a particular population of vesicles in fast 
anterograde axonal transport. 
The Journal of Cell Biology, Volume  129, 1995  164 Figure 9. Electron micrographs of affinity purified KIF2-assoeiated vesicles. The surface of anti-KIb'2 antibody-conjugated (A, C, and 
D) or normal mouse IgG conjugated beads (B and E) after being incubated with the crude membrane fraction. At lower magnification, 
membranous organelles were visible on the anti-KIF2 antibody conjugated bead (A, arrowheads), but not on the normal mouse immuno- 
globulin conjugated one (B). Higher magnification (C, D, and E) showed KIF2-associated vesicles are observed as relatively uniform 
particles with a diameter of 100-120 nm. Multivesicular bodies are also found. Bars: (A and B) 2 t~m; (C, D, and E) 200 nm. 
KIF2 Has a Unique Structure Distinct from Kinesin 
The primary structure of KIF2 has a conserved motor do- 
main at the center of the molecule, being different from that 
located at the NH2 terminus in conventional kinesins and 
that at the COOH terminus in other groups of kinesin-like 
proteins such as KAR3 and ncd (Meluh et ai.,  1990; Mc- 
donald  and  Goldstein,  1990;  Endow  et  al.,  1990).  Sf9- 
expressed recombinant KIF2, similar to kinesin, exists as a 
homodimer, binds microtubules in a ATP-dependent man- 
ner,  and translocates microtubules as a  plus-end-directed 
motor. However, analysis of its submolecular structure by 
low-angle rotary shadowing EM and the quick-freeze deep- 
etch method showed it consists of a single large globular do- 
main (16.4  +  0.2 nm) and has a short stalk domain which 
could only be observed by the latter method. KIF2's NH2- 
terminal structure may contribute to the formation of this 
bigger globular domain with motor domain,  producing a 
structure totally unique  from other kinesin-like proteins. 
Moreover, the absence of a light chain also contradicts con- 
ventional structural patterns. Its biochemical properties sug- 
gest the presence of another microtubule binding site which 
is ATP independent and which enables it to cross-bridge be- 
tween  microtubules  and  bundle  them  as  observed in  the 
quick-freeze samples. On the other hand, no evidence exists 
that  KIF2  bundles  microtubules  in  vivo,  instead  moving 
along microtubules: hence, suggesting this phenomenon may 
only be observed in vitro and is not physiological. Immuno- 
precipitation  of  native  KIF2  in  soluble  fractions  using 
anti-KIF2 antibodies showed it has no associated protein like 
kinesin's  light  chain.  Because  our  immunoprecipitation 
results  using  antibody-labeled  beads  revealed  that  KIF2 
binds to a particular population of small vesicles, its tail do- 
main is likely to function in vitro as a binding site for as- 
sociated vesicles rather than microtubules.  Although  this 
new protein shows a unique structure distinct from kinesin 
and other KIFs, the ubiquitous distribution and existence of 
new homologues such as CHO26 and DFLP1 (Sekine et al., 
1994; Wordeman et al.,  1995) suggest it may be a new fam- 
ily which plays a  fundamental role regarding species and 
tissues. 
KIF2 Functions in Growing Axons 
in the Nervous System 
KIF2 is dominantly expressed in the nervous system of mice, 
especially in juvenile brain, though it is expressed in all tis- 
sues (Fig. 4, B and C). Its continuous existence in olfactory 
bulbs, where neuite outgrowth and plasticity persist for life 
(Graziadei et al., 1979), also supports its function in the de- 
veloping  brain.  Immunocytochemistry of the  cerebellum 
showed that KIF2 is abundant in growing axons, and was 
condensed in parallel fibers of granular cells on postnatal 
day 7 (P7), disappearing from the inner side at P14, similar 
to MAP1B (Schoenfeld et al.,  1989; Sato-Yoshitake  et al., 
1989) (Fig. 5). Subcellular fractionation of embryonal brain 
also demonstrated KIF2's abundance in growth cones (Fig. 
7 B). Concerning KIF2's function in vivo, two possibilities 
exist: (a) in the juvenile brain, KIF2 transports an abundant 
cargo; and (b) KIF2's cargo exists in all stages of  nervous sys- 
tem development, being succeeded to be transported by an- 
other motor appearing at a later stage. Western blotting anal- 
ysis showed that KIF2 still exists in adult brain, though its 
level is close to the sensitivity of immunocytochemistry. Our 
PCR cloning has not yet led to discovering another protein 
which is similar to KIF2 and becomes a counterpart in adult 
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able.  We expect that quantitative identification will ulti- 
mately shed light on this question. 
KIF2-associated Vesicles  Are Different 
from Synaptic Vesicles 
KIF2 exists in membrane-bound form rather than in soluble 
form in vivo (Fig. 7).  When we isolated KIF2-associated 
membranous organelles by the immunological method, they 
were found to be free of other motors such as kinesin and 
KIF3A (Fig.  8), being transported anterogradely in axons 
(Fig. 6). This behavior suggests that they are only conveyed 
by KIF2 which is abundant in developing brain. Moreover, 
subcellular fractionation also showed these vesicles to be 
distributed differently from kinesin and KIF3A (Fig. 8). Al- 
though we have not isolated kinesin- or KIF3A-associated 
vesicles, this data suggests a possibility that some motors ex- 
ist which convey specific cargo.  Previous data on a kinesin 
mutant (Gho et al., 1992),  which apparently did not influ- 
ence synaptic vesicle concentration, and unc-104 (Otsuka et 
al., 1991), a putative kinesin-like motor specific for synaptic 
vesicles, support this possibility. 
KIF2 is  relatively concentrated in  the  synaptic vesicle 
fraction, as well as in the microsomal one (Fig. 7). Subcellu- 
lar fractionation of embryonal mouse brain also showed its 
abundance in growth cones in membrane-bound form, which 
resembles synaptophysin and SV2, both membrane markers 
of synaptic vesicles. However, on the contrary, developmen- 
tal regulation separates KIF2 from synaptophysin and SV2. 
The distribution pattern of accumulated KIF2 in the prox- 
imal region of ligated nerves is also atypical (Fig. 6), com- 
pared with other KIFs (Hirokawa et al., 1991; Kondo et al., 
1994), and differs from that of synaptophysin and SV2 (data 
not shown) since the accumulated portion tended to be more 
distant from the ligated region. EM indicated that the di- 
ameter of KIF2-associated vesicles is between 100-120  nm, 
different from typical synaptic vesicles (Fig. 9), while immu- 
noprecipitation of KIF2-associated vesicles and purification 
of synaptic vesicles by CPG column clearly show that they 
are  distinct  from  synaptic  vesicles  and  their  precursors 
(Mundigl et al.,  1993;  Feany et al.,  1993). 
The identification of axonal transport motors enables re- 
searchers to clarify and differentiate the transport mecha- 
nism carried by each motor. We expect that the presented 
results will provide the foundation for discovering functional 
diversity and redundancy of the motor proteins in the ner- 
vous system. Future work will be directed at examining the 
co-localization  of  other  membrane  markers  with  KIF2- 
associated vesicles,  and hopefully this will reveal  KIF2's 
specific function in the nervous system. 
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